Development of Biopolymer Nanoparticles for Precise Diagnostics and Targeted Therapy of Prostate Cancer Using Radioisotopes.

Development of Biopolymer Nanoparticles for Precise Diagnostics and Targeted Therapy of Prostate Cancer Using Radioisotopes.

Development of Biopolymer Nanoparticles for Precise Diagnostics and Targeted Therapy of Prostate Cancer Using Radioisotopes.

Between 2016 and 2020, the company NanoThea carried out a project co-financed by the European Funds titled “Development of Biopolymer Nanoparticles fo…

Biopolymer Nanoparticles as Carriers of Radioactive Isotopes for Early Cancer Diagnosis.

Biopolymer Nanoparticles as Carriers of Radioactive Isotopes for Early Cancer Diagnosis.

POIR.01.01.01-00-0289/16-01 Between 2016 and 2020, the company NanoThea carried out a project co-financed by the European Funds titled “Biopolymer Nan…

Preclinical and Clinical Studies of Innovative Nanopharmaceutical Formulations for Cancer Therapy.

Preclinical and Clinical Studies of Innovative Nanopharmaceutical Formulations for Cancer Therapy.

POIR.01.01.01-00-0021/16-00 As part of this project, NanoVelos plans to conduct industrial research aimed at encapsulating a range of chemot…

NanoGroup: Shareholders increase their involvement in the company

NanoGroup: Shareholders increase their involvement in the company

– Summing up – it has been a good year for #NanoGroup S.A. We have even more ambitious goals and plans for the future – says Przemysław Mazurek

pp-thumbnail